Skip to main content
A

ADIMMUNE CORPORATION — Investor Relations & Filings

Ticker · 4142 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Filings indexed 1,793 across all filing types
Latest filing 2026-03-05 Regulatory Filings
Country TW Taiwan
Listing TW 4142

About ADIMMUNE CORPORATION

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
115年02月董事會成員及持股
Regulatory Filings
2026-03-05 Chinese
115年02月內部人持股異動(事後)
Regulatory Filings
2026-03-05 Chinese
公告本公司民國114年度財務報告提報董事會召開日期
Regulatory Filings
2026-03-03 Chinese
公告本公司財務主管異動
Regulatory Filings
2026-03-02 Chinese
115年1月營業收入
Regulatory Filings
2026-02-10 Chinese
115年1月背書保證與資金貸與
Regulatory Filings
2026-02-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.